The percentage of brain weight was similar among the three groups at P1, P20 and 13 weeks
Want proven, FDA-approved, on-demand use
Mol Cell Proteomics 9:25172528
This communication should include detailed description of the side effect (what symptoms are experienced, when they started, how severe they are), timing relative to IGF1 LR3 use (when was the last dose, how long after use did symptoms begin), any actions already taken (interventions tried, their effectiveness), and current status (whether symptoms are improving, stable, or worsening)
However, compared with the self-quenched AuNCs, the present work is much simpler and straightforward, exhibits higher quantum yield, a lower limit of detection (up to 40 times) and better selectivity over other interfering species